Navigation Links
MD Coder Pocket PC 2006

ProductsMD Coder Pocket PC 2006
Company Mobile Design Technologies, Inc.
Item MD Coder Pocket PC 2006
Features 
  • Comprehensive patient tracking
  • Categorized, cross-referenced CPT and ICD-9 Codes
  • Create customizable ICD-9 and CPT-4 Favorites Lists on the handheld
  • Updated 2005 CPT and ICD-9 codes
  • Ability to carry over charges from the previous day
  • Create custom ICD-9 and CPT-4 lists on the PC application and syncronize your lists to one or more handhelds
  • An enhanced patient display that supports 100+ on-device patients
  • Bi-directional synchronization between Handheld and PC application
  • Reporting, printing, and exporting features from the MD Coder PC application
  • Patient summary and charge reporting in HTML, XML and TXT files on the PocketPC Device
  • Add any existing CPT or ICD code on the handheld to your favorites list
  • Customize the look of your patient list
  • Sort codes on the handheld by either number or by description
  • An export module so you can use your data in other databases: Excel, Acrobat, and other applications
Description MD Coder Charge Capture Pocket PC Edition is a charge capture tool. We have integrated the feedback from hospitals and physicians. MD Coder Charge Capture supports both the Palm OS and Pocket PC platforms.
Info Mobile Design Technologies, Inc.
Customer Service: (713) 554-5300
Web site: http://www.mobiledesigntech.com/

Related medicine products :

1. STAT ICD-9 Coder
2. STAT CPT Coder
3. STAT E&M Coder
4. MD Coder v6.0
5. MD Coder 2006
6. MD Coder Web Edition 2006
7. Pocket Pachymeter
8. Pocket Direct Ophthalmoscope
9. Pocket Red Filter
10. PocketChem UA
11. Pocket II Precision Pachymeter
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 1COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 2Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 1Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4